title: [Contribution of biochemical tests in the diagnosis of the nervous phase of human African trypanosomiasis].
abstract: The stage of human African trypanosomiasis (HAT) is important to define precisely as far as it is directly related to the type of treatment used. The beginning of the neurological involvement is difficult to find out because there is no known specific clinical or biological sign. This study is trying to look for a precise marker and has been realized in Congo. 70 subjects with parasitologically confirmed HAT and 70 controls are included. The stage of HAT is determined according to the classical definition on the field using the cerebrospinal fluid (CSF) cell count: less than 5 cells/microliters for the first stage (P1), more than 5 cells/microliters for the second stage (P2). The blood analysis has included: glucose, urea, creatinine, sodium, potassium, calcium, chloride, phosphorus, uric acid, total bilirubin, unconjugated bilirubin, total cholesterol, triglycerides, total proteins, aspartate aminotransferase, alanine aminotransferase, creatinine phosphokinase, alkaline phosphatase, gamma-glutamyltransferase, immunoglobulins M and G, C3c fraction of complement, transferrin, seromucoid alpha 1, haptoglobin and albumin. In CSF we have analyzed IgM, IgG, protein levels and the bloodbrain barrier (BBB) impairment. The comparison between the subjects and their controls, the subjects in P1 and in P2, the CSF cell count and the other CSF alterations show the interest of the IgM level in CSF and the BBB impairment to identify subjects in P2. However there is a low gradation in the biological disturbances and not a precise threshold point. Nevertheless it seems reasonable to raise the CSF cell count level to 20 cells/microliters to define the beginning of the nervous involvement.
authors.affiliation: Institut d'épidémiologie neurologique et de neurologie tropicale, Faculté de médecine, Limoges, France.
authors.forename: S
authors.initials: S
authors.lastname: Bisser
authors.forename: B
authors.initials: B
authors.lastname: Bouteille
authors.forename: J
authors.initials: J
authors.lastname: Sarda
authors.forename: A
authors.initials: A
authors.lastname: Stanghellini
authors.forename: D
authors.initials: D
authors.lastname: Ricard
authors.forename: M O
authors.initials: MO
authors.lastname: Jauberteau
authors.forename: F
authors.initials: F
authors.lastname: Marchan
authors.forename: M
authors.initials: M
authors.lastname: Dumas
authors.forename: J C
authors.initials: JC
authors.lastname: Breton
mesh_terms: D001774:Blood Chemical Analysis; D002555:Cerebrospinal Fluid / Q000166:cytology; D002556:Cerebrospinal Fluid Proteins / Q000134:cerebrospinal fluid; D006801:Humans; D007074:Immunoglobulin G / Q000134:cerebrospinal fluid; D007075:Immunoglobulin M / Q000134:cerebrospinal fluid; D009422:Nervous System Diseases / Q000134:cerebrospinal fluid / Q000175:diagnosis* / Q000469:parasitology*; D014353:Trypanosomiasis, African / Q000097:blood / Q000134:cerebrospinal fluid / Q000150:complications*
chemical_list: D002556:Cerebrospinal Fluid Proteins; D007074:Immunoglobulin G; D007075:Immunoglobulin M
vernacular_title: Apport des examens biochimiques dans le diagnostic de la phase nerveuse de la trypanosomose humaine africaine.